89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 39 filers reported holding 89BIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,965,421 | -15.5% | 580,662 | +3.8% | 0.00% | 0.0% |
Q2 2023 | $10,605,027 | +585.4% | 559,632 | +450.9% | 0.00% | – |
Q1 2023 | $1,547,246 | +88.9% | 101,592 | +57.9% | 0.00% | – |
Q4 2022 | $818,870 | +105.7% | 64,326 | -6.3% | 0.00% | – |
Q3 2022 | $398,000 | +255.4% | 68,677 | +98.1% | 0.00% | – |
Q2 2022 | $112,000 | -69.8% | 34,676 | -64.8% | 0.00% | – |
Q1 2022 | $371,000 | -72.3% | 98,567 | -3.7% | 0.00% | – |
Q4 2021 | $1,339,000 | -33.8% | 102,390 | -0.9% | 0.00% | – |
Q3 2021 | $2,024,000 | -10.9% | 103,272 | -14.9% | 0.00% | – |
Q2 2021 | $2,271,000 | -20.8% | 121,414 | +0.2% | 0.00% | -100.0% |
Q1 2021 | $2,869,000 | -15.8% | 121,145 | -13.4% | 0.00% | 0.0% |
Q4 2020 | $3,409,000 | +17.1% | 139,885 | +23.4% | 0.00% | 0.0% |
Q3 2020 | $2,910,000 | +79.7% | 113,399 | +39.5% | 0.00% | – |
Q2 2020 | $1,619,000 | +49.4% | 81,267 | +89.2% | 0.00% | – |
Q1 2020 | $1,084,000 | +38.3% | 42,944 | +44.0% | 0.00% | – |
Q4 2019 | $784,000 | – | 29,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |